The unequal scramble for coronavirus vaccines — by the numbers

  title={The unequal scramble for coronavirus vaccines — by the numbers},
  author={E. Callaway},
  pages={506 - 507}
Wealthy countries have already pre-ordered more than two billion doses. Wealthy countries have already pre-ordered more than two billion doses. 
After A COVID-19 Vaccine: Collaboration Or Competition?
As COVID-19 vaccines and therapies emerge, critical questions remain about access and affordability around the world.
COVID-19 vaccines: challenges and promises of trials, manufacturing and allocation of doses
Tweetable abstract Reflections on challenges and promises of COVID-19 vaccine development show opportunities for innovation and collaboration between stakeholders.
Country Level Preparation for the Deployment of COVID-19 Vaccine
Coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory SyndromeCorona Virus 2 (SARS-CoV-2), has significantly impacted every aspect of human life globally. DevastatingExpand
Equitable Access to COVID-19 Vaccines: Cooperation around Research and Production Capacity Is Critical
A policy platform is proposed to promote a more equitable roll out of vaccines in the context of the COVID-19 pandemic including: full funding of Covax and expansion of local production of vaccines supported by technology transfer and an immediate waiver of key provisions of the TRIPS Agreement. Expand
Could fluvoxamine keep COVID-19 patients out of hospitals and intensive care units?
Limited production capacities and vaccine hesitancy could impede a global post-COVID19 recovery, particularly in developing countries. Expand
Disproportionate coronavirus disease 2019 (COVID-19) vaccine distribution—A great threat to low- and middle-income countries
This book aims to provide a history of veterinary medicine in Pakistan by highlighting the role of modern medicine and its applications in the treatment of infectious diseases. Expand
Africa Needs a New Public Health Order to Tackle Infectious Disease Threats
The SARS-CoV-2 pandemic has revealed that Africa needs a new public health order to be resilient, to adapt, and to cope with 21st-century disease threats. The new order will need strengthenedExpand
COVID-19 vaccines pricing policy options for low-income and middle- income countries
The COVID-19 pandemic limits pricing policy options, so it is necessary to consider what appropriate policy options governments can use to ensure affordable and equitable access to these novel products. Expand
COVID-19: Rethinking the Lockdown Groupthink
  • A. Joffe
  • Medicine
  • Frontiers in Public Health
  • 2021
A cost-benefit analysis of the response to CO VID-19 finds that lockdowns are far more harmful to public health than COVID-19 can be, and suggests focused protection of those truly at high risk, opening of schools, and building back better with a economy are suggested. Expand
Vaccines for All: Challenges and Potential Solutions for Equitable COVID-19 Vaccine Distribution (Preprint)
As several COVID-19 vaccine candidates are being approved for human use, governments around the world are preparing comprehensive frameworks and protocols to address potential obstacles for equitableExpand